Drug Trial Radar · NCT07230119
A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1)
Last checked: Nov 20, 2026Latest source record: Aug 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
755
Actual
Start
Jan 16, 2026
Primary completion
May 29, 2027
Study completion Jun 26, 2027
Sponsor
- Lead sponsor
- Beijing QL Biopharmaceutical Co.,LtdIndustry
- Sponsor type
- Industry
- First posted
- Nov 17, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the percentage change in body weight from baseline and proportion of subjects achieving ≥ 5% weight loss from baseline after 52 weeks of treatment with Zovaglutide in subjects with overweight/obesity.
Conditions
- Overweight , Obesity
Interventions
Zovaglutide dose 1Drug
administered subcutaneously (SC), Q4W
Zovaglutide dose 2Drug
administered subcutaneously (SC), Q4W
PlaceboDrug
administered subcutaneously (SC), Q4W
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in body weight(%)Time frame: baseline (week 0) to week 52
- Proportion of subjects achieving ≥ 5% weight lossTime frame: 52 weeks
Locations
45 sites in 1 country. Site status is shown where the registry gives one.
Peking University People's Hospital
Beijing, China
Xuancheng People's Hospital
Xuancheng, Anhui, China
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijiing, China
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Gansu Provincial Hospital
Lanzhou, Gansu, China
Guangzhou Red Cross Hospital
Guangzhou, Guangdong, China
Huizhou Central People's Hospital
Huizhou, Guangdong, China
The Second Affiliated Hospotal of Guangxi Medical University
Nanning, Guangxi, China
Handan First Hospital
Handan, Hebei, China
Hebei Petro China Cental Hospital
Langfang, Hebei, China
First Hospital of Qinhuangdao
Qinhuangdao, Hebei, China
The Second Hospital of Hebei Medical University
Shijiangzhuang, Hebei, China
Harbin Medical University Affiliated Fourth Hospital
Harbin, Heilongjiang, China
The First Affiliated Hospital of Henan University of Science & Technology
Luoyang, Henan, China
Luoyang Third People's Hospital
Luoyang, Henan, China
The First Affiliated of Nanyang Medical College
Nanyang, Henan, China
Nanyang Second People's Hospital
Nanyang, Henan, China
Sanmenxia Central Hospital
Sanmenxia, Henan, China
Wuhan No.3 Hospital
Wuhan, Hubei, China
Yichang Central People's Hospital (Xiling Campus)
Yichang, Hubei, China
Yichang Central People's Hospital
Yichang, Hubei, China
The First People's Hospital of Changde
Changde, Hunan, China
Yueyang Central Hospital
Yueyang, Hunan, China
Yueyang People's Hospital
Yueyang, Hunan, China
Zhuzhou Central Hospital
Zhuzhou, Hunan, China
The Second People's Hospital of Lianyungang
Lianyungang, Jiangsu, China
Nanjing Jiangning Hospital
Nanjing, Jiangsu, China
The Second Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
The Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China
Jiangxi Provincial People's Hospital
Nanchang, Jiangxi, China
Jilin Province FAW General Hospital
Changchun, Jilin, China
The Third Affiliated Hospital of Jinzhou Medical University
Jinzhou, Liaoning, China
The Fifth People's Hospital of Shenyang
Shenyang, Liaoning, China
Binzhou Medical University Hospital
Binzhou, Shandong, China
Central Hospital Affiliated to Shandong First Medical University
Jinan, Shandong, China
Zibo Central Hospital
Zibo, Shandong, China
Zibo Municipal Hospital
Zibo, Shandong, China
Jincheng General Hospital
Jincheng, Shanxi, China
Xi'an Daxing Hospital
Xi’an, Shanxi, China
Yan'an University Xianyang Hospital
Yanan, Shanxi, China
Showing 40 of 45 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.